Clinical Trials Logo

Clinical Trial Summary

The femoro-popliteal arterial segment is one of the most frequent locations for atherosclerosis. Its management is mainly endovascular (standard and coated-balloon angioplasty, stenting).

However, the structural features of the atherosclerotic disease in regards to patient's risk factors and past medical and surgical histories are not well studied. Furthermore, the histological analysis of the femoro-popliteal arterial segment is rare in the literature, and made difficult mostly because of the length of this segment.

There is a clinical need for better understanding of atherosclerotic lesions in this location, with as further goal, a better management of this disease.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03847597
Study type Observational
Source University Hospital, Strasbourg, France
Contact Nabil CHAKFE
Phone +33 3 69 55 08 88
Email nabil.chakfe@chru-strasbourg.fr
Status Not yet recruiting
Phase
Start date April 2019
Completion date February 2022

See also
  Status Clinical Trial Phase
Recruiting NCT00768495 - Hyperspectral Imaging Pre and Post Endovascular Intervention N/A
Completed NCT03294902 - Improving Radiological Outcomes in Arterial Disease - A Pilot Evaluation of the Pedra Tissue Perfusion Monitoring System
Active, not recruiting NCT02908035 - Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO) Phase 2
Active, not recruiting NCT02479620 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization Phase 2
Recruiting NCT02479555 - Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Percutaneous Transluminal Angioplasty Revascularization Phase 2
Recruiting NCT06416644 - The PORTuguese Registry of Supera Supported Femoral-Fopliteal Revascularization (SupPORT Registry) N/A